As we step into 2020, we are reminded of our successes from the past year and the challenges and opportunities before us. Last year, SNI held true to its mission of supporting cross-member learning by hosting five in-person meetings for nearly 400 attendees and 66 webinars for over 2,400 participants on topics such as social needs screenings and data analytics for population health.
Public health care systems also completed year four of the PRIME program – an ambitious five year pay-for-performance initiative, which drives performance improvement and value-based care. On our recent PRIME webinar, Los Angeles County Department of Health Services and UC San Diego, shared their implementation experiences with a focus on how the program has impacted patient care.
At the CAPH/SNI Annual Conference this past December, we recognized the exceptional efforts of several members with the Quality Leaders Awards (QLA), which showcase innovative approaches to advance care and population health. The 2019 QLA winners focused on caring for complex patients, including those facing homelessness, behavioral health, and/or substance use, and addressing patients’ social needs.
With our signature waiver programs expiring at the end of this year, we are working hard alongside members to help inform the next iteration of Medi-Cal. Although there are always challenges inherent with change, we know that transition brings opportunity and we continue to support and accelerate the great work of public health care systems in California.
We hope you enjoy this edition of the SNI Forward.
Giovanna Giuliani
Executive Director
California Health Care Safety Net Institute
Program Highlight – WIT
During the annual conference, SNI hosted the tenth Waiver Integration Team+ (WIT+) Convening, bringing together over 100 clinical, operational, and data leaders to discuss how waiver programs will evolve after 2020, including through changes outlined in the Department of Health Care Services’ (DHCS) Medi-Cal Healthier California for All proposal (formerly CalAIM).
Participants assessed opportunities related to DHCS’ Population Health Management Program (PHMP), which ties together several of the Medi-Cal Healthier California for All proposals that impact public health care systems. Participants spoke with their teams and with other system leaders about how they are preparing for the changes ahead, including the roles and responsibilities of public health care systems and health plans under the PHMP transition. Other topics related to Medi-Cal Healthier California for All were discussed, including health and social needs assessments, data sharing, enhanced care management, in-lieu-of-services, and the Quality Incentive Program (QIP).
WIT+ attendees left the convening with a deeper understanding of Medi-Cal Healthier California for All and initial strategies to plan for the transition with health plan partners.
By the Numbers – PRIME
The Public Hospital Redesign and Incentives in Medi-Cal (PRIME) program, now in its fifth and final year, continues to improve quality and health outcomes for patients. Based on data from program year four, CAPH/SNI members met 88% of their pay-for-performance (P4P) targets.
As shown, PRIME has made an impressive impact on the lives of patients in several key areas, such as blood pressure control, depression and tobacco screening, and collection of data on sexual orientation and gender identity, referred to as SOGI.
In December, over 100 attendees joined our PRIME webinar to learn more about year four performance trends. Two members, Los Angeles County Department of Health Services and UC San Diego, shared on the ground examples of patient impact across their systems.
Every year, at the CAPH/SNI Annual Conference, we present the Quality Leaders Awards (QLA) to highlight our members’ innovative approaches to providing high-value, high-quality, patient-centered care. Learn more about the outstanding 2019 winners below.
Top Honor – Santa Clara Valley Medical Center
To improve care for patients with complex needs, such as homelessness, substance use disorder, and mental illness, Santa Clara Valley Medical Center developed the Post-Acute Care Transitions (PACT) initiative to coordinate seamless transitions from the hospital to a nursing home, where patients can access medical and social services to facilitate their return to the community.
Performance Excellence – San Joaquin General Hospital
To better care for patients with heart failure and related hospital admissions, San Joaquin General Hospital redesigned their heart failure clinic to improve access, ensure supportive transitions of care, and address social needs.
Data-Driven Organization – Riverside University Health System
To address patients’ unidentified non-physical health needs,Riverside University Health System created the Whole Person Health Score, a comprehensive physical, emotional, and social health assessment to engage patients on what matters most to them.
Ambulatory Care Redesign – LAC+USC Medical Center
To address the opioid epidemic, LAC+USC Medical Center Adult Primary Care implemented a series of interventions, including improving patient-provider continuity, increasing visit frequency, and empowering pharmacy oversight, to safely reduce opioid prescribing for patients experiencing chronic, non-cancer pain
What’s Next
Highlights from SNI Programs in the Upcoming Quarter
Whole Person Care: The Essential Role of Community Health Workers & Peers – On February 13, CAPH/SNI will partner with the Camden Coalition of Healthcare Providers, the California Health Care Foundation, and county associations to host a workshop for Whole Person Care pilots to share promising practices for strengthening and sustaining the community health worker and peer workforce.
QIP Readiness Meeting – On April 2, SNI will convene PRIME and QIP leaders, program managers, and reporting analysts to share learnings from four years of PRIME and two years of QIP, and how members are preparing for the next iteration of QIP, which will include measures from both programs.
Approval to use both PRIME and QIP Reporting Manuals and associated code sets
Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association, Pharmacy Quality Alliance and by CMS Medicaid Adult and Child Core Set. You are not authorized to download the materials unless you read, agree to and abide by the provisions of the copyright statements. Read the following copyright statements now:
AMA Copyright Statement
The five character codes included in the PRIME Reporting Manual DY14, PRIME Reporting Manual DY15, QIP Reporting Manual for PY2 Year End Reporting, QIP Reporting Manual for PY3 Year End Reporting and the QIP Reporting Manual for PY3.5 Year End Reporting are obtained from Current Procedural Terminology (CPT®), copyright 2019 by the American Medical Association (AMA). CPT is developed by the AMA as a listing of descriptive terms and five character identifying codes and modifiers for reporting medical services and procedures.
The responsibility for the content of PRIME Reporting Manual DY14, PRIME Reporting Manual DY15, QIP Reporting Manual for PY2 Year End Reporting, QIP Reporting Manual for PY3 Year End Reporting and the QIP Reporting Manual for PY3.5 Year End Reporting is with SNI and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable or related to any use, nonuse or interpretation of information contained in PRIME Reporting Manual DY14, PRIME Reporting Manual DY15, QIP Reporting Manual for PY2 Year End Reporting, QIP Reporting Manual for PY3 Year End Reporting and the QIP Reporting Manual for PY3.5 Year End Reporting. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Any use of CPT outside of PRIME Reporting Manual DY14, PRIME Reporting Manual DY15, QIP Reporting Manual for PY2 Year End Reporting, QIP Reporting Manual for PY3 Year End Reportingand the QIP Reporting Manual for PY3.5 Year End Reporting should refer to the most current Current Procedural Terminology which contains the complete and most current listing of CPT codes and descriptive terms. CPT is a registered trademark of the American Medical Association.
LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)
CPT only copyright 2019 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
You, your employees and agents are authorized to use CPT only as contained in the PRIME Reporting Manual DY14, PRIME Reporting Manual DY15, QIP Reporting Manual for PY2 Year End Reporting, QIP Reporting Manual for PY3 Year End Reporting, and QIP PY3.5 Reporting Manual - solely for your own personal use and only for participating in state governmental healthcare related programs supported by and/or administered by SNI. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this Agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site (http://info.commerce.ama-assn.org/ama-data-file-request-0).
U.S. Government Rights
This product includes CPT which is commercial technical data, which was developed exclusively at private expense by the American Medical Association (AMA), 330 North Wabash Avenue, Chicago, Illinois 60611. The AMA does not agree to license CPT to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The AMA reserves all rights to approve any license with any Federal agency.
Disclaimer of Warranties and Liabilities.
CPT is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with SNI, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.
This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.
Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “I agree”.
Pharmacy Quality Alliance Copyright Statement
By agreeing to this policy, user accepts the following limitations of the PRIME and QIP use of the Pharmacy Quality Alliance (PQA) Opioid measures and code sets: To accurately calculate the measure rates, the PQA NDC files are required. User acknowledges that the PQA measures and NDC files will only be used for the sole purpose of evaluating and improving opioid use for populations being served by Public Health Care Systems (PHS) and by District and Municipal Hospitals (DMPH) and will not be used for other purposes within user. Except for the purpose indicated above, the measures and NDC file will not be used in any other commercial product, service or value-added benefit. User also acknowledges that the information and lists will not be forwarded or provided to anyone outside of SNI, the California Department of Health Care Services DHCS, the PHS or the DMPH.
PQA retains the rights to these measures and can rescind or alter the measures at any time. PQA may approve an organization’s use of the measures; however, no organization may use the measures without first obtaining permission from PQA prior to using the measures. Certain uses of the measures are only approved with a licensing agreement from PQA that specifies the terms of use and the licensing fee. PQA reserves the right to determine the conditions under which it will approve use and/or license the measures. Users of the measure shall not have the right to alter, enhance, or otherwise modify the measures.
CMS Medicaid Adult and Child Core Set License Agreements
Please review the licensing information below and indicate your agreement and acceptance.
LICENSE FOR USE OF PHYSICIANS' CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (CPT)
End User Point and Click Agreement:
CPT codes, descriptions and other data only are copyright 2017 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association (AMA).
You, your employees and agents are authorized to use CPT only as contained in the following authorized materials of Centers for Medicare and Medicaid Services (CMS) internally within your organization within the United States for the sole use by yourself, employees and agents. Use is limited to use in Medicare, Medicaid or other programs administered by CMS. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60654. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt.
Applicable FARS\DFARS Restrictions Apply to Government Use. This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60654. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
AMA Disclaimer of Warranties and Liabilities.
CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this agreement.
CMS Disclaimer
The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.
Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "Accept".
LICENSE FOR USE OF CURRENT DENTAL TERMINOLOGY (CDT™)
THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED “ACCEPT”, YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.<.p>
IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED “DO NOT ACCEPT” AND EXIT FROM THIS COMPUTER SCREEN.
IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, “YOU” AND “YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.
1. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
2. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association web site, http://www.ADA.org/ .
3. Applicable Federal Acquisition Regulation Clauses (FARS)\Department of restrictions apply to Government Use. Please click here to see all U.S. Government Rights Provisions.
4. ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT IS PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES O F MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. NO FEE SCHEDULES, BASIC UNIT, RELATIVE VALUES OR RELATED LISTINGS ARE INCLUDED IN CDT. THE ADA DOES NOT DIRECTLY OR INDIRECTLY PRACTICE MEDICINE OR DISPENSE DENTAL SERVICES. THE SOLE RESPONSIBILITY FOR THE SOFTWARE, INCLUDING ANY CDT AND OTHER CONTENT CONTAINED THEREIN, IS WITH (INSERT NAME OF APPLICABLE ENTITY) OR THE CMS; AND NO ENDORSEMENT BY THE ADA IS INTENDED OR IMPLIED. THE ADA EXPRESSLY DISCLAIMS RESPONSIBILITY FOR ANY CONSEQUENCES OR LIABILITY ATTRIBUTABLE TO OR RELATED TO ANY USE, NON-USE, OR INTERPRETATION OF INFORMATION CONTAINED OR NOT CONTAINED IN THIS FILE/PRODUCT. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third party beneficiary to this Agreement.
5. CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT should be addressed to the ADA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. IN NO EVENT SHALL CMS BE LIABLE FOR DIRECT, INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE USE OF SUCH INFORMATION OR MATERIAL.
LICENSE FOR NATIONAL UNIFORM BILLING COMMITTEE (NUBC)
These materials contain NUBC Official UB-04 Specifications (UB-04 Data), which is copyrighted by the American Hospital Association (AHA).
THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.
IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.
IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.
Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use UB-04 Data only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of UB-04 Data is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this Agreement. You acknowledge that the AHA holds all copyright, trademark and other rights in UB-04 Data. You shall not remove, alter, or obscure any AHA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including, by way of illustration and not by way of limitation, making copies of UB-04 Data for resale and/or license, transferring copies of UB-04 Data to any party not bound by this agreement, creating any modified or derivative work of UB-04 Data, or making any commercial use of UB-04 Data. License to use UB-04 Data for any use not authorized herein must be obtained through the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois, 60606. Applications are available at the NUBC website, http://www.nubc.org/.
The UB-04 Data included in this product is commercial technical data and/or computer databases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois 60606. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
AHA DISCLAIMER OF WARRANTIES AND LIABILITIES. UB-04 Data is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. The sole responsibility for the software, including any UB-04 Data and other content contained therein, is with the Medicare/Medicaid Contractor or the CMS; and no endorsement by the AHA is intended or implied. The AHA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The AHA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the AHA, the copyright holder. Any questions pertaining to the license or use of the UB-04 Data should be addressed to the AHA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE UB-04 DATA. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.
During the annual conference, SNI hosted the tenth Waiver Integration Team+ (WIT+) Convening, bringing together over 100 clinical, operational, and data leaders to discuss how waiver programs will evolve after 2020, including through changes outlined in the Department of Health Care Services’ (DHCS) Medi-Cal Healthier California for All proposal (formerly CalAIM).
As shown, PRIME has made an impressive impact on the lives of patients in several key areas, such as blood pressure control, depression and tobacco screening, and collection of data on sexual orientation and gender identity, referred to as SOGI.